Trials / Conditions / Stage III Renal Pelvis and Ureter Cancer AJCC v8
Stage III Renal Pelvis and Ureter Cancer AJCC v8
3 registered clinical trials studyying Stage III Renal Pelvis and Ureter Cancer AJCC v8.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in NCT05092958 | National Cancer Institute (NCI) | Phase 3 |
| Terminated | Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary NCT04398368 | Mayo Clinic | Phase 2 |
| Active Not Recruiting | Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourin NCT02496208 | National Cancer Institute (NCI) | Phase 1 |